PWMG
KRTX

Prestige Wealth Management Group’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Prestige Wealth Management Group’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6
Closed -$1.9K – 1054
2023
Q4 		$1.9K Buy
+6
New +$1.17K ﹤0.01% 756

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Prestige Wealth Management Group's KRTX Position: Q1 2024 in Review

Prestige Wealth Management Group sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 6 shares — an estimated $1.9K sold.

Prestige Wealth Management Group first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $1.9K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Prestige Wealth Management Group reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Prestige Wealth Management Group sold 6 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.9K.
  • Prestige Wealth Management Group first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Prestige Wealth Management Group's Karuna Therapeutics, Inc. Common Stock position peaked at $1.9K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Prestige Wealth Management Group's 13F filing for Q1 2024, filed 26 Apr 2024.